Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shakiba Jalilevand"'
Autor:
Atefeh Zandifar, Rahim Badrfam, Ahmad Shamabadi, Shakiba Jalilevand, Shayan Pourmirbabaei, Farbod Torkamand, Erfan Sahebolzamani, Shahin Akhondzadeh
Publikováno v:
Iranian Journal of Psychiatry, Vol 16, Iss 1 (2021)
Objective: Major depressive disorder (MDD) is predicted to be the first cause of burden of disease. The antidepressant activity of gemfibrozil has been recently considered. This study was designed to evaluate the effectiveness of gemfibrozil as a ser
Externí odkaz:
https://doaj.org/article/41e9c57053f54eaa9340aa22359c7aa8
Autor:
Ahmad Shamabadi, Erfan Sahebolzamani, Shakiba Jalilevand, Atefeh Zandifar, Rahim Badrfam, Shayan Pourmirbabaei, Shahin Akhondzadeh, Farbod Torkamand
Publikováno v:
Iranian Journal of Psychiatry
Iranian Journal of Psychiatry, Vol 16, Iss 1 (2021)
Iranian Journal of Psychiatry, Vol 16, Iss 1 (2021)
Objective: Major depressive disorder (MDD) is predicted to be one of the biggest disease burden in the future. The antidepressant activity of gemfibrozil has been recently considered. In this study, we assessed the effectiveness of gemfibrozil as a s
Autor:
Salomeh Ghaffari, Ali Aqamolaei, Ahmad Shamabadi, Mohammd Reza Shalbafan, Sina Naderi, Shahin Akhondzadeh, Rosa Alikhani, Seyyed Hosein Mortazavi, Erfan Sahebolzamani, Seiedeh Bentolhoda Mousavi, Shakiba Jalilevand, Arash Sadri, Amirhosein Mortezaei, Farzaneh Yousefzadeh
Publikováno v:
International Clinical Psychopharmacology. 35:254-262
On the basis of numerous previous studies, the serotonergic system plays a role in the pathogenesis of obsessive-compulsive disorder (OCD) and effective agents in this pathway, such as 5-hydroxytryptophan, can potentially contribute to treatment of p
Autor:
Amirhosein Mortezaei, Sina Naderi, Mohammad Reza Mohammadi, Shahin Akhondzadeh, Seyyed Hosein Mortazavi, Sara Baziar, Ali Aqamolaei, Ebrahim Khadem, Mahsa Shahmirzadi, Erfan Sahebolzamani, Shakiba Jalilevand
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 29:205-212
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders of childhood and adolescence. About 30% of patients do not respond to stimulants or cannot tolerate their side effects. Thus, alternative medication,